???global.info.a_carregar???
Inês Vasconcelos completed a Bachelors and Masters degree in Biochemistry by the Faculty of Sciences of the Universidade of Porto. Currently attends the Masters degree in Medicine by the School of Medicine of the University of Minho and the Doctoral program in Cardiovascular Sciences of the Faculty of Medicine of the University of Porto. Published 5 articles in journals. Has 1 section(s) of books. Has received 1 award. Works in the area of Basic and Clinical Medicine with an emphasis on Physiology and Cardiac and Cardiovascular Systems.
Identification

Personal identification

Full name
Inês Francisca Gouveia Vasconcelos

Citation names

  • Vasconcelos, Inês

Author identifiers

Ciência ID
3713-4FB7-3446
ORCID iD
0000-0002-4870-9946

Knowledge fields

  • Medical and Health Sciences - Basic Medicine - Physiology
  • Medical and Health Sciences - Clinical Medicine - Cardiac and Cardiovascular Systems

Languages

Language Speaking Reading Writing Listening Peer-review
Portuguese (Mother tongue)
English Proficiency (C2) Proficiency (C2) Proficiency (C2) Proficiency (C2) Proficiency (C2)
Spanish; Castilian Intermediate (B1) Intermediate (B1) Intermediate (B1) Intermediate (B1) Intermediate (B1)
French Beginner (A1) Elementary (A2) Beginner (A1) Elementary (A2) Beginner (A1)
Education
Degree Classification
2022 - 2026
Ongoing
Medicina (Mestrado integrado)
Universidade do Minho Escola de Medicina, Portugal
2021 - 2025
Ongoing
Ciências Cardiovasculares (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
2019/09 - 2021/12
Concluded
Bioquímica (Mestrado)
Universidade do Porto Faculdade de Ciências, Portugal
"Role of Urocortin-2 in Heart Failure with preserved Ejection Fraction - pathophysiological and therapeutic implications" (THESIS/DISSERTATION)
18
2016 - 2019
Concluded
Bioquímica (Licenciatura)
Universidade do Porto Faculdade de Ciências, Portugal
"Exploring a mucosal vaccination approach against Neospora caninum infection" (THESIS/DISSERTATION)
15
Affiliation

Science

Category
Host institution
Employer
2020 - Current Researcher (Research) Universidade do Porto Faculdade de Medicina, Portugal
Projects

Grant

Designation Funders
2023 - Current Relaxin-2 and Pulmonary Arterial Hypertension: pathophysiological role and therapeutic potential
2022.08921.PTDC
Researcher
Ongoing

Other

Designation Funders
2020 - Current The role of urocortin-2 in in heart failure with preserved ejection fraction
-
Researcher
Universidade do Porto Faculdade de Medicina, Portugal
Outputs

Publications

Book chapter
  1. Inês Vasconcelos; Francisco Pérez-Vizcaíno; Adelino Leite-Moreira; Carmen Brás-Silva; Rui Adão. "Glycolysis in pulmonary arterial hypertension and metabolic reprogramming". 267-296. Elsevier, 2024.
    10.1016/b978-0-323-91704-9.00008-2
Conference abstract
  1. Vaz-Salvador, Pedro; Vasconcelos, Inês. "Role of Urocortin-2 in Heart Failure with Preserved Ejection Fraction - pathophysiological and therapeutic implications.". Paper presented in XXXIII Jornadas de Terapêutica, Porto, 2021.
    Published
Journal article
  1. Inês Vasconcelos; Madalena von Hafe; Rui Adão; Adelino Leite-Moreira; Carmen Brás-Silva. "Corticotropin-releasing hormone and obesity: From fetal life to adulthood". Obesity Reviews (2024): https://doi.org/10.1111/obr.13763.
    10.1111/obr.13763
  2. Inês Vasconcelos; Tiago Santos. "Nanotechnology Applications in Sepsis: Essential Knowledge for Clinicians". Pharmaceutics (2023): https://doi.org/10.3390/pharmaceutics15061682.
    10.3390/pharmaceutics15061682
  3. Gomes, Joana; Ferreira, Pedro; Adão, Rui; Rocha, Carolina; Vasconcelos, Inês; Rego, Beatriz; Vaz-Salvador, Pedro; Moreira, Adelino; Silva, Carmén. "THERAPEUTIC EFFECTS OF NEBULIZATION- BASED DELIVERY OF ANTI-MIR-146A IN EXPERIMENTAL PULMONARY ARTERIAL HYPERTENSION". Journal of Hypertension 40 Suppl 1 (2022): e37-e38. http://dx.doi.org/10.1097/01.hjh.0000835592.72344.ff.
    10.1097/01.hjh.0000835592.72344.ff
  4. Vaz-Salvador, Pedro; Adão, Rui; Vasconcelos, Inês; Leite-Moreira, Adelino F.; Brás-Silva, Carmen. "Heart Failure with Preserved Ejection Fraction: a Pharmacotherapeutic Update". Cardiovascular Drugs and Therapy (2022): http://dx.doi.org/10.1007/s10557-021-07306-8.
    Published • 10.1007/s10557-021-07306-8
  5. Vasconcelos, Inês; Adão, Rui; Rademaker, Miriam T.; Leite-Moreira, Adelino F.; Fontes-Sousa, Ana Patrícia; Brás-Silva, Carmen. "Urocortins as biomarkers in cardiovascular disease". Clinical Science 136 1 (2021): 1-14. http://dx.doi.org/10.1042/cs20210732.
    Published • 10.1042/cs20210732
Activities

Oral presentation

Presentation title Event name
Host (Event location)
2024/04 Urocortin-2 as a novel biomarker of clinical deterioration in HFpEF: A prospective cohort study. Congresso Português de Cardiologia
2022/11 Urocortin-2 and its effects in an animal model of metabolic syndrome. 1st Conference of the Doctoral Program in Metabolism - Clinical and Experimental
(Porto, Portugal)
2022/11 Therapeutic implications of urocortin-2 in Heart Failure with preserved Ejection Fraction. Congresso Internacional da Sociedade Portuguesa de Fisiologia
(Coimbra, Portugal)
2022/08 Pathophysiological and therapeutic implications of urocortin-2 in heart failure with preserved ejection fraction. ESC Congress
(Barcelona, Spain)
2022/08 Therapeutic effects of nebulization- based delivery of anti-miR-146a in experimental pulmonary arterial hypertension. ESC Congress
(Barcelona, Spain)
2022/06 Therapeutic effects of nebulization- based delivery of anti-miR-146a in experimental pulmonary arterial hypertension. 31st European Meeting on Hypertension and Cardiovascular Protection
(Athens, Greece)
2022/05 The role of miR-146a in the pathophysiology of pulmonary arterial hypertension - therapeutic implications. Heart Failure Congress
(Madrid, Spain)
2022/05 Therapeutic effects of urocortin-2 in Heart Failure with preserved Ejection Fraction. Heart Failure Congress
(Madrid, Spain)
2022/04 Therapeutic effect of Urocortin-2 in Heart Failure with Preserved Ejection Fraction. Congresso Português de Cardiologia 2022
(Albufeira, Portugal)
2022/04 Therapeutic effects of nebulization- based delivery of anti-miR-146a in experimental pulmonary arterial hypertension. Congresso Português de Cardiologia
(Albufeira, Portugal)
2022/03 Pathophysiological and therapeutic implications of Urocortin-2 in Heart Failure with Preserved Ejection Fraction. AIMS meeting 2022 - Annual International (bio)Medical Students Meeting
(Lisboa, Portugal)
2021/09 Pathophysiological and therapeutic implications of Urocortin-2 in Heart Failure with Preserved Ejection Fraction. YES meeting 16th edition – Young European Scientist Meeting
(Porto, Portugal)
2021/09 The role of miR-146a in the pathophysiology of pulmonary arterial hypertension. YES meeting 16th edition – Young European Scientist Meeting
(Porto, Portugal)
2021/05/08 The role of Urocortin-2 in Heart Failure with Preserved Ejection Fraction. VI Jornadas de Bioquímica
(Porto, Portugal)
2021/05/07 Ucns as biomarkers in cardiovascular disease. IJUP 14th edition - Encontro de Investigação Jovem da Universidade do Porto
(Porto, Portugal)
2021/05/07 The role of miR-146a in the pathophysiology of pulmonary arterial hypertension. IJUP 14th Edition - Encontro de Investigação Jovem da Universidade do Porto.
(Porto, Portugal)

Mentoring / Tutoring

Topic Student name
2022/09/05 - 2022/09/10 16ª Escola de Ciências da Vida e da Saúde - Quando o coração falha: do laboratório à clínica Maura Silva, Rita Garcia
Distinctions

Award

2022 AIMS meeting 2022 - Research Competition